首页> 外文期刊>Journal of Clinical Microbiology >Establishing a Method of Inoculum Preparation for Susceptibility Testing of Trichophyton rubrum and Trichophyton mentagrophytes
【24h】

Establishing a Method of Inoculum Preparation for Susceptibility Testing of Trichophyton rubrum and Trichophyton mentagrophytes

机译:建立用于接种红毛癣菌和毛癣菌的药敏试验的接种物制备方法

获取原文
           

摘要

A total of 92 clinical isolates of dermatophytes (52 of Trichophyton rubrum and 40 of Trichophyton mentagrophytes) were selected for testing with six antifungal drugs (terbinafine, griseofulvin, clotrimazole, miconazole, isoconazole, and fluconazole) and two pairs of drug combinations (ketoconazole-cyclopiroxolamine and itraconazole-cyclopiroxolamine). Two methods of inoculum preparation for susceptibility testing were evaluated that used (i) inocula consisting only of microconidia of dermatophytes filtered in Whatman filter model 40 and (ii) unfiltered inocula consisting of hyphae and microconidia. We followed the recommendations of approved document M38-A of CLSI (formerly NCCLS) with some adaptations, including an incubation period of 7 days and an incubation temperature of 28°C. Reference strains of Candida parapsilosis, Candida krusei, Trichophyton rubrum, and Trichophyton mentagrophytes were included as quality-control strains. MICs were consistently higher (usually 1 to 2 dilutions for drugs tested individually) when nonfiltered inocula were tested (P < 0.01) except for terbinafine. Larger MICs were seen when testing drugs with nonfiltered inocula. The curves of drug interaction were used to analyze the reproducibility of the test, and it was shown that high levels of reproducibility were achieved using the methodology that included the filtration step. The standardization of methodologies is the first step to yield reliability of susceptibility testing and to proceed with clinical laboratory studies to correlate MICs with clinical outcomes.
机译:总共选择了92种皮肤真菌的临床分离株(毛癣菌的52个和毛癣菌的的40个)对六种抗真菌药物(特比萘芬,灰黄霉素,克霉唑,咪康唑,异康唑和氟康唑)和两对药物组合(酮康唑-环吡醇胺和伊曲康唑-环吡醇胺)。评价了两种用于药敏试验的接种物制备方法,这些方法使用(i)仅由经Whatman过滤器型号40过滤的皮肤真菌的微分生孢子组成的接种物,和(ii)由菌丝和微分生孢子组成的未过滤接种物。我们遵循了CLSI(原NCCLS)的批准文件M38-A的建议,并进行了一些修改,包括7天的潜伏期和28°C的孵育温度。包括 Candida parapsilsilosis,克鲁斯假丝酵母,红毛癣菌毛癣菌的参考菌株作为质量控制菌株。除特比萘芬外,未过滤接种物的MIC( P <0.01)始终较高(通常为单独测试的药物为1至2稀释)。使用未经过滤的接种液测试药物时观察到较大的MIC。药物相互作用的曲线用于分析测试的重现性,结果表明,使用包括过滤步骤的方法,可以实现高水平的重现性。方法的标准化是第一步,要提高药敏试验的可靠性,并继续进行临床实验室研究,以使MIC与临床结果相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号